The fibroblast never planned on a career change. For years, it sat quietly in atrial tissue, minding its own business, patching up minor wear and tear like a dependable road crew filling potholes. But somewhere along the route between a breast tumor and the heart's upper chambers, a signal arrived...
That single word carries more weight in oncology than most people realize. For over half a century, I have watched the field chase shiny new molecules - and occasionally stumble upon something remarkable hiding in plain sight inside the medicine cabinet. Ponatinib, a drug that has spent the better...
Going once, going twice - sold to the oncologist recycling the same drug class! In the high-stakes auction of cancer treatment options, what happens when you've already played your best card and need to bid again with something suspiciously similar? That's the question a team of researchers just...
Ladies and gentlemen of the jury, the prosecution would like to present Exhibit A: glioblastoma multiforme (GBM), the most aggressive brain tumor known to medicine, a repeat offender with a rap sheet longer than a Law & Order marathon. For decades, the defense - our immune system - has been...
Your Gut Is Prime Real Estate - And Someone Finally Sent in an Inspector
Meanwhile, in a breast cancer cell's nucleus, thousands of long non-coding RNAs are lounging around like freeloaders at a party nobody remembers inviting them to. Scientists used to think these molecular squatters were just "junk" transcripts - the biological equivalent of that one drawer in your...
Think of your bone marrow as a building's plumbing system - a sprawling, intricate network of pipes carrying signals that tell blood cells when to grow, when to stop, and when to gracefully retire. Now imagine one of those pipes - let's call it FLT3 - develops a kink. Not the kind a plumber fixes...
Making a soufflé without a recipe is a bold move. Making one without ever having tasted a soufflé? That's basically what cancer genomics has been trying to do every time it analyzes a tumor sample without its matching "normal" DNA reference. You're staring at thousands of genetic changes, trying to...
When we last left our heroes, the plucky engineered immune cells known as CAR T cells had conquered lymphoma and myeloma with the swagger of a championship team on a winning streak. But AML - acute myeloid leukemia - remained the villain they couldn't quite crack. The tumor microenvironment was...
"But wait, there's more!" If your immune system's anti-cancer squad has been underperforming - if those T-cells are dragging themselves through the tumor microenvironment like contestants on season 47 of Survivor - then boy, does Roche have the infomercial product for you. Introducing tobemstomig:...
Members of the jury, the evidence is in. For years, the case against recurrent head and neck squamous cell carcinoma (HNSCC) has felt almost unwinnable. The prosecution - an army of surgeons, oncologists, and radiation therapists - threw everything they had at the tumor the first time around....
In Ant-Man and the Wasp, the heroes discover that the key to saving the day isn't some galaxy-sized weapon - it's mastering the quantum realm, a world so tiny it makes atoms look like beach balls. Turns out, cancer researchers have been on a remarkably similar quest. Deep inside your cells,...
A fly on the wall in the offices of JAMA this spring would have witnessed something remarkable: a polite but pointed academic cage match over one of the biggest questions in cancer medicine. On one side, three epidemiologists - Frerik Smit, Jay Kaufman, and Arnaud Chiolero - raising an eyebrow at...
The pathologist was halfway through her third coffee when the mass spectrometer spat out something that made her set the mug down. Buried in the proteomic data from 759 tumor samples, six proteins were practically screaming about which stage III colon cancer patients would relapse - and which ones...
Triple-negative breast cancer is the villain nobody roots for. It's aggressive, it's sneaky, and it refuses to carry the molecular handles - estrogen, progesterone, and HER2 receptors - that doctors normally grab onto when selecting treatments. About 30% of TNBC patients who receive neoadjuvant...
Deep inside the bone marrow, a covert operation has been running for decades. Acute myeloid leukemia - AML for short - is the double agent that slipped past your body's counterintelligence, forging fake IDs for rogue blood cells and smuggling them into circulation. For years, oncologists have been...
That's not the sound of a bug zapper on your porch. It's the sound of electric fields scrambling cancer cells in someone's pancreas - and the FDA just gave it a thumbs up.
Dear ovarian cancer,
Breast cancer has been playing chess while we've been stuck playing checkers. For decades, this cellular villain has watched us throw the exact same screening playbook at every single woman who walks through the door - annual mammograms, same age cutoffs, rinse and repeat - like a heist movie where...
If tumors ever handed out report cards, most cancer biologists would still be getting an Incomplete in "How Cells Actually Spread." We've spent decades studying individual cancer cells sneaking off on their own little field trips through the body, only to discover that the real troublemakers are...